ICOA
ZVRA icon

Investment Centers of America’s Zevra Therapeutics ZVRA Stock Holding History

Investment Centers of America’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-656
Closed -$152K – 557
2016
Q1 		$152K Buy
+656
New +$159K 0.02% 485

Other funds holding ZVRA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Investment Centers of America's ZVRA Position: Q2 2016 in Review

Investment Centers of America sold out of Zevra Therapeutics (ZVRA) in Q2 2016, closing a stake of 656 shares — an estimated $152K sold.

Investment Centers of America first reported a position in ZVRA in Q1 2016 and held it in 1 quarter. The position peaked at $152K in Q1 2016. 40 funds tracked by Wall St. Rank hold ZVRA as of Q2 2016.

  • Investment Centers of America reported no remaining Zevra Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Investment Centers of America sold 656 Zevra Therapeutics shares in Q2 2016, an estimated $152K.
  • Investment Centers of America first reported a position in Zevra Therapeutics in Q1 2016 and held it in 1 quarter.
  • Investment Centers of America's Zevra Therapeutics position peaked at $152K in Q1 2016.
  • 40 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2016.

Based on Investment Centers of America's 13F filing for Q2 2016, filed 9 Aug 2016.